TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.220
-0.040 (-1.23%)
At close: May 26, 2026, 4:00 PM EDT
3.160
-0.060 (-1.86%)
After-hours: May 26, 2026, 7:47 PM EDT
TriSalus Life Sciences Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, TriSalus Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $8.80. The average 1-year stock price forecast is 173.29% higher than the current stock price, while the lowest is $7.00 (+117.39%) and the highest is $11 (+241.61%).
Price Target: $8.80 (+173.29%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TriSalus Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Reiterates $8 | Buy | Reiterates | $8 | +148.45% | May 19, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $10 | Buy | Reiterates | $10 | +210.56% | May 14, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $11 | Buy | Reiterates | $11 | +241.61% | May 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $7 | Buy | Maintains | $7 | +117.39% | May 13, 2026 |
| Northland Securities | Northland Securities | Buy Reiterates $13 → $8 | Buy | Reiterates | $13 → $8 | +148.45% | Mar 23, 2026 |
Financial Forecast
Revenue This Year
55.96M
from 45.15M
Increased by 23.95%
Revenue Next Year
83.48M
from 55.96M
Increased by 49.17%
EPS This Year
-0.39
from -1.84
EPS Next Year
-0.09
from -0.39
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 63.0M | 96.4M | ||||||
| Avg | 56.0M | 83.5M | ||||||
| Low | 47.6M | 71.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 39.5% | 72.3% | ||||||
| Avg | 23.9% | 49.2% | ||||||
| Low | 5.5% | 28.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.34 | 0.22 | |
| Avg | -0.39 | -0.09 | |
| Low | -0.45 | -0.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.